XL-844

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameXL-844
Drug Alias NameEXEL-9844XL-844
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 2 inhibitorsCheckpoint kinase 1 inhibitors
TargetsCheckpoint kinase 2Checkpoint kinase 1
Therapy Area/IndicationsLymphomaLeukemia, Lymphocytic, Chronic, B-CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExelixis Inc
Active IndicationsN/A
Inactive IndicationsLymphomaLeukemia, Lymphocytic, Chronic, B-CellNeoplasms

Other Information

ATC CodeN/A
Related LinksDrugBank